Page last updated: 2024-08-21

2-tert-butylhydroquinone and Apnea, Obstructive Sleep

2-tert-butylhydroquinone has been researched along with Apnea, Obstructive Sleep in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jiang, W; Liu, H; Liu, L; Wang, L; Yue, S; Zhang, H; Zheng, P; Zhou, L; Zhou, Y	1

Other Studies

1 other study(ies) available for 2-tert-butylhydroquinone and Apnea, Obstructive Sleep

Article	Year
Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway. Life sciences, 2021, Nov-15, Volume: 285 Topics: Animals; Cell Line; Hepatocytes; Humans; Hydroquinones; Hypoxia; Male; Mice; Mice, Inbred Strains; Necroptosis; NF-E2-Related Factor 2; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Sleep Apnea, Obstructive	2021

Article

Year

Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway.

Life sciences, 2021, Nov-15, Volume: 285

Topics: Animals; Cell Line; Hepatocytes; Humans; Hydroquinones; Hypoxia; Male; Mice; Mice, Inbred Strains; Necroptosis; NF-E2-Related Factor 2; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Sleep Apnea, Obstructive

2021